Skip to main content
Khalil Choucair, MD, Oncology, Detroit, MI

KhalilChoucairMDMSc.

Oncology Detroit, MI

Hematologic Oncology

Chief Fellow

Dr. Choucair is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Choucair's full profile

Already have an account?

  • Office

    Karmanos Cancer Institute
    4100 John R St
    Detroit, MI 48201
    Phone+1 800-527-6266

Education & Training

  • Detroit Medical Center/Wayne State University
    Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 2022 - 2025
  • University of Kansas (Wichita)
    University of Kansas (Wichita)Residency, Internal Medicine, 2019 - 2022
  • American University of Beirut Faculty of Medicine
    American University of Beirut Faculty of MedicineClass of 2018
  • McGill University
    McGill University MSc., Experimental Medicine , 2009 - 2011
  • McGill University
    McGill University BSc, Biology , Great distinction, 2007 - 2009

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2022 - 2025
  • KS State Medical License
    KS State Medical License 2019 - 2022
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • W. C. (Carter) Goodpasture Resident Performance Award University of Kansas School of Medicine, 2022
  • Outgoing Chief Resident Award University of Kansas School of Medicine, 2022
  • KU Annual Research Award University of Kansas School of Medicine, 2022
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Anti-Inflammatory and Immune Properties of Polyunsaturated Fatty Acids (PUFAs) and Their Impact on Colorectal Cancer (CRC) Prevention and Treatment  
    Alireza Tojjari, Khalil Choucair, Arezoo Sadeghipour, Azhar Saeed, Anwaar Saeed, Cancers, 8/28/2023
  • Molecular characterization and clinical outcomes of pancreatic neuroendocrine tumors (pNENs) harboring PAK4-NAMPT alterations.  
    Ibrahim Azar, Nishant Gandhi, Misako Nagasaka, Jun Gong, Bassel Nazha, Khalil Choucair, Moh'd M Khushman, Heloisa P Soares, Wafik S El-Deiry, Philip Agop Philip, Emil ..., Journal of Clinical Oncology, 1/2/2023
  • Clinical evaluation of ramucirumab for the treatment of hepatocellular carcinoma: place in therapy  
    Khalil Choucair, Syed Kamran and Anwaar Saeed, Onco Targets and Therapy, 12/1/2021

Abstracts/Posters

  • Age-associated differences in transcriptional expression and tumor immune microenvironment composition among older patients with cancer
    Khalil Choucair, Abdul Rafeh Naqash, April K.S. Salama, Chul Kim, Andrew Elliott, Matthew James Oberley, Phillip Walker, Azhar Saeed, Wafik S. El-Deiry, Himisha Beltra..., Journal of Clinical Oncology/American Society of Clinical Oncology 2022, Chicago, 6/1/2022
  • . Clinical utility of genomic recurrence risk stratification in early, hormone-receptor-positive, human epidermal growth factor receptor 2-negative breast cancer
    Khalil Choucair, Seth Joel Page, Bassam Ibrahim Mattar, Christopher Dakhil, Nassim H. Nabbout, Jeremy Michael Deutsch, Quoc Van Truong, Phu Van Truong, Dennis Frederic..., Journal of Clinical Oncology/American Society of Clinical Oncology 2022, Chicago, 6/1/2022
  • Phase II Trial of Moderate Dose Omega-3 Acid Ethyl Esters for Colorectal Cancer Prevention in Patients with Lynch Syndrome (COLYNE)
    Khalil Choucair, Dan Dixon, Ajay Bansal, Jennifer R. Klemp, Yazan Abdulateef, Prabhakar Chalise, Raed Moh'd Taiseer Al-Rajabi, Anup Kasi, Stephen K. Williamson, Joaqui..., Journal of Clinical Oncology/ASCO GI series, San Francisco, 1/19/2022

Professional Memberships

Other Languages

  • Arabic, French